[Ip-health] Patents Against People: How Drug Companies Price Patients out of Survival
b.baker at neu.edu
Tue Oct 1 10:30:06 PDT 2013
This is a strong, passionate article describing the battle being waged between pharma and patients.
Michelle Chen, Patents Against People: How Drug Companies Price Patients out of Survival, Dissent (Fall 2013) http://www.dissentmagazine.org/article/patents-against-people-how-drug-companies-price-patients-out-of-survival
Professor Brook K. Baker
Northeastern U. School of Law
Affiliate, Program on Human Rights and the Global Economy
400 Huntington Ave.
Boston, MA 02115 USA
Honorary Research Fellow, University of KwaZulu Natal, Durban, S. Africa
Senior Policy Analyst Health GAP (Global Access Project)
Alternate NGOs Board Member UNITAID
b.baker at neu.edu<mailto:b.baker at neu.edu>
More information about the Ip-health